FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2512577044> ?p ?o ?g. }

• W2512577044 endingPage "65875" @default.
• W2512577044 startingPage "65862" @default.
• W2512577044 abstract "// Bo Cheng 1, 2 , Guosheng Yang 2, 3 , Rui Jiang 1 , Yong Cheng 1 , Haifan Yang 1 , Lijun Pei 1 , Xiaofu Qiu 2, 3 1 Department of Urology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China 2 Southern Medical University, Guangzhou 510280, China 3 Department of Urology, Guangdong No.2 Provincial People’s Hospital, Guangzhou 510317, China Correspondence to: Guosheng Yang, email: 2008yangguosheng@sina.com Rui Jiang, email: jiangrui@126.com Keywords: renal cancer, prognosis, cancer stem cells, biomarker, meta-analysis Received: March 31, 2016     Accepted: August 10, 2016     Published: August 29, 2016 ABSTRACT Background: Relevant markers of CSCs may serve as prognostic biomarkers of RCC. However, their actual prognostic significance remains inconclusive. Thus, a meta-analysis was performed to reevaluate the association of CSCs-relevant markers (CXCR4, CD133, CD44, CD105) expression with RCC prognosis more precisely. Methods: PubMed and Embase were searched to look for eligible studies. The pooled hazard ratios (HR) with 95% confidence intervals (95% CI) were used to reassess the association of CSCs markers expression and RCC prognosis of overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and progression-free survival (PFS). Results: There were 25 relevant articles, encompassing 2673 RCC patients, eligible for meta-analysis. Overall pooled analysis suggested that high CSCs markers expression predicted poor OS (HR, 2.10, 95% CI: 1.73–2.55) and DFS (HR, 3.77, 95% CI: 2.30–6.19). High CXCR4 expression predicted worse OS (HR, 2.57, 95% CI: 1.95–3.40), CSS (HR,1.97, 95% CI: 1.50–2.59), and DFS (HR, 5.82, 95% CI: 3.01–11.25). CD44 over-expression correlated with a poor OS(HR,1.58, 95% CI: 1.14–2.18), CSS (HR, 2.58, 95% CI: 1.27–5.23), and DFS (HR, 4.49, 95% CI: 2.12–9.53) in RCC patients. CD133 was an independent favorable prognostic factor for CSS (HR, 0.4, 95% CI: 0.29–0.54). Conclusions: The presence of CSCs markers correlates with poor RCC outcome. CSCs may be potentially utilized as prognostic markers to stratify RCC patients, probably representing also a novel potential therapeutic target." @default.
• W2512577044 created "2016-09-16" @default.
• W2512577044 creator A5004408436 @default.
• W2512577044 creator A5004809139 @default.
• W2512577044 creator A5009181954 @default.
• W2512577044 creator A5012697945 @default.
• W2512577044 creator A5021139854 @default.
• W2512577044 creator A5064931816 @default.
• W2512577044 creator A5066786708 @default.
• W2512577044 date "2016-08-29" @default.
• W2512577044 modified "2023-10-03" @default.
• W2512577044 title "Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis" @default.
• W2512577044 cites W1030263894 @default.
• W2512577044 cites W1492250592 @default.
• W2512577044 cites W1494244942 @default.
• W2512577044 cites W1498201286 @default.
• W2512577044 cites W1517288051 @default.
• W2512577044 cites W1527381664 @default.
• W2512577044 cites W1549811545 @default.
• W2512577044 cites W1589571763 @default.
• W2512577044 cites W1941872196 @default.
• W2512577044 cites W1959431242 @default.
• W2512577044 cites W1964435302 @default.
• W2512577044 cites W1980475208 @default.
• W2512577044 cites W1984135992 @default.
• W2512577044 cites W1984958970 @default.
• W2512577044 cites W1987977871 @default.
• W2512577044 cites W1989482324 @default.
• W2512577044 cites W1998728654 @default.
• W2512577044 cites W1999053847 @default.
• W2512577044 cites W2011387027 @default.
• W2512577044 cites W2015386991 @default.
• W2512577044 cites W2018248081 @default.
• W2512577044 cites W2020539578 @default.
• W2512577044 cites W2023497129 @default.
• W2512577044 cites W2025185222 @default.
• W2512577044 cites W2044253536 @default.
• W2512577044 cites W2066612813 @default.
• W2512577044 cites W2068574409 @default.
• W2512577044 cites W2075983064 @default.
• W2512577044 cites W2078980580 @default.
• W2512577044 cites W2088095316 @default.
• W2512577044 cites W2088933551 @default.
• W2512577044 cites W2097940882 @default.
• W2512577044 cites W2118492595 @default.
• W2512577044 cites W2125481638 @default.
• W2512577044 cites W2126541203 @default.
• W2512577044 cites W2134630203 @default.
• W2512577044 cites W2137160884 @default.
• W2512577044 cites W2141110984 @default.
• W2512577044 cites W2143753251 @default.
• W2512577044 cites W2146257635 @default.
• W2512577044 cites W2147243234 @default.
• W2512577044 cites W2152696412 @default.
• W2512577044 cites W2154224826 @default.
• W2512577044 cites W2161763362 @default.
• W2512577044 cites W2164317031 @default.
• W2512577044 cites W2168878075 @default.
• W2512577044 cites W2174994139 @default.
• W2512577044 cites W2183212613 @default.
• W2512577044 cites W2235523093 @default.
• W2512577044 cites W2291038537 @default.
• W2512577044 cites W2312660694 @default.
• W2512577044 cites W2323561519 @default.
• W2512577044 cites W2407454067 @default.
• W2512577044 cites W2816965188 @default.
• W2512577044 cites W2911611736 @default.
• W2512577044 cites W2991792334 @default.
• W2512577044 cites W2156144274 @default.
• W2512577044 cites W56544914 @default.
• W2512577044 doi "https://doi.org/10.18632/oncotarget.11672" @default.
• W2512577044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5323198" @default.
• W2512577044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27588469" @default.
• W2512577044 hasPublicationYear "2016" @default.
• W2512577044 type Work @default.
• W2512577044 sameAs 2512577044 @default.
• W2512577044 citedByCount "28" @default.
• W2512577044 countsByYear W25125770442016 @default.
• W2512577044 countsByYear W25125770442017 @default.
• W2512577044 countsByYear W25125770442018 @default.
• W2512577044 countsByYear W25125770442019 @default.
• W2512577044 countsByYear W25125770442020 @default.
• W2512577044 countsByYear W25125770442021 @default.
• W2512577044 countsByYear W25125770442023 @default.
• W2512577044 crossrefType "journal-article" @default.
• W2512577044 hasAuthorship W2512577044A5004408436 @default.
• W2512577044 hasAuthorship W2512577044A5004809139 @default.
• W2512577044 hasAuthorship W2512577044A5009181954 @default.
• W2512577044 hasAuthorship W2512577044A5012697945 @default.
• W2512577044 hasAuthorship W2512577044A5021139854 @default.
• W2512577044 hasAuthorship W2512577044A5064931816 @default.
• W2512577044 hasAuthorship W2512577044A5066786708 @default.
• W2512577044 hasBestOaLocation W25125770441 @default.
• W2512577044 hasConcept C121608353 @default.
• W2512577044 hasConcept C126322002 @default.
• W2512577044 hasConcept C129470790 @default.
• W2512577044 hasConcept C13373296 @default.
• W2512577044 hasConcept C143998085 @default.

• next